Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A
- PMID: 3045820
- PMCID: PMC282027
- DOI: 10.1073/pnas.85.18.6612
Human immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin A
Abstract
The protease encoded by the human immunodeficiency virus (HIV) processes the viral gag and gag-pol protein precursor by posttranslational cleavage. In this study we have demonstrated by site-specific mutagenesis (Asp----Thr) and by pepstatin A inhibition that the recombinant HIV protease is an aspartic-type protease. Furthermore, incubation of HIV-infected H9 cells with pepstatin A inhibited part of the intracellular processing of the HIV gag protein yet had no apparent toxicity on HIV-infected cells during 48 hr of incubation.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
